
About Maxtar Bio-Genics Private Limited
Data last updated:
Maxtar Bio-Genics Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC121514. Its GSTIN is 06AADCM9577C1ZB (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.1 Lakh. It is led by directors Madan Lal Bansal and Jagdish Chand Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 310 3rd Floor W Mall, Mangalam Palace Sector – 3 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.22 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹29.4 Lakh (net margin 68%) and EBITDA of ₹41.41 Lakh (EBITDA margin 95.8%). Revenue has declined at a compounded annual rate (CAGR) of 57% over three years and 36% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxtarbiogenics.com.
Company details
Contact details
Maxtar Bio-Genics Private Limited's registered office is in Delhi, Delhi. Its website is maxtarbiogenics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address310 3rd Floor W Mall, Mangalam Palace Sector – 3 Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxtar Bio-Genics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxtar Bio-Genics is real estate. In detail, this covers real estate activities with own or leased property.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property |
To see the full business activity and turnover split of Maxtar Bio-Genics Private Limited, buy the company report.
Financials of Maxtar Bio-Genics Private Limited
FY 2025 filings availableMaxtar Bio-Genics Private Limited reported revenue of ₹43.22 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 36% over five years, including a 12% fall in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 95.8% | ||||
| Net Profit Margin | 68% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxtar Bio-Genics Private Limited, buy the company report.
Board of directors of Maxtar Bio-Genics Private Limited
Maxtar Bio-Genics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Lal Bansal | Director | 14 Jan 2009 | 17 Years 10 Months | Current |
| Jagdish Chand Bansal | Director | 29 Jul 2003 | 23 Years 3 Months | Current |
Auditor
Maxtar Bio-Genics Private Limited is audited by AGGARWAL DHEERAJ & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGGARWAL DHEERAJ & ASSOCIATES | FY 2023 | 040522N |
Shareholding
The shareholding of Maxtar Bio-Genics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxtar Bio-Genics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jul 2021 | 100477785 | Hdfc Bank Limited | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Maxtar Bio-Genics Private Limited has 2 court cases on record: 1 filed by Maxtar Bio-Genics, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Punjab and Haryana | Writ petition | Filed by the company against State of Haryana and Others | Disposed |
| District court, North, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Maxtar Bio-Genics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Maxtar Bio-Genics Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier |
To see the full MSME payment records of Maxtar Bio-Genics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Maxtar Bio-Genics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCM9577C1ZB | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxtar Bio-Genics Private Limited, buy the company report.
Recent activity
Maxtar Bio-Genics Private Limited has 6 board changes on record since 2003: 4 appointments and 2 cessations. The latest: Kunal Kakkar ceased to be Director on 10 Nov 2023.
Frequently asked questions
Maxtar Bio-Genics is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 July 2003 (23+ years old) and is registered under CIN U24239DL2003PTC121514.
Maxtar Bio-Genics has 2 current directors:
- Madan Lal Bansal - Director
- Jagdish Chand Bansal - Director
The latest financial statements of Maxtar Bio-Genics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxtar Bio-Genics is 06AADCM9577C1ZB, registered in Haryana.
The CIN (Corporate Identification Number) of Maxtar Bio-Genics is U24239DL2003PTC121514. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxtar Bio-Genics has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Maxtar Bio-Genics was incorporated on 29 July 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Kunal Kakkar ceased to be Director on 10 Nov 2023. Kunal Kakkar was appointed as Director on 25 Mar 2021. Rakesh Bansal ceased to be Director on 04 Dec 2018. Maxtar Bio-Genics has 6 board changes on record in total.
Maxtar Bio-Genics has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 11 May 2019.
Maxtar Bio-Genics can be reached through the website maxtarbiogenics.com. Its registered office is in Delhi, India.
The registered office of Maxtar Bio-Genics is at 310 3rd Floor W Mall, Mangalam Palace Sector – 3 Rohini, Delhi, India – 110085.

